Kiniksa Pharmaceuticals · 23 hours ago
Receptionist/Administrative Assistant
Kiniksa Pharmaceuticals is a company focused on developing innovative therapies, and they are seeking a Receptionist/Administrative Assistant to provide support across various departments. The role involves greeting visitors, handling calls, maintaining records, and assisting with onboarding processes.
BiopharmaBiotechnologyMedical
Responsibilities
Greet visitors and maintain a visitor logbook
Direct calls from world-wide customers, subsidiaries, and representatives
Issue and track visitor badges to adhere to strict EHS/Security Visitor policy regulation
Direct visitors to their destinations
Keep the lobby area neat and clean at all times
Provide training to administrative staff on the phone system and offer on-demand support as needed
Escalate issues related to the facility in a timely manner
Maintain record of monthly receipts and invoices for the Associate Director, Facilities
Communicate with key department personnel to order office supplies. Additionally, maintain accurate inventory of supplies needed
Order companywide snacks and beverages. Assist with inventory check, as needed
Assist in onboarding processes for incoming new hires
Manage Career Calendar to provide seamless candidate experience
Perform ad-hoc clerical/administrative projects as deemed necessary by manager
Qualification
Required
Requires previous reception and/or office experience in a professional environment
Ability to meet, greet and converse with employees, customers, visitors, and vendors/suppliers with a positive attitude
Strong written and verbal communication, and organizational skills
Ability to maintain a calm, courteous and professional demeanor at all times
Ability to multi-task
Ability to communicate effectively
Strong commitment to compliance and ethical standards
Proficient with Microsoft Office suite (i.e., Word, PowerPoint, Excel, Outlook, SharePoint, etc.)
Company
Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.
Funding
Current Stage
Public CompanyTotal Funding
$400MKey Investors
Baker Brothers Advisors LLC
2020-05-13Post Ipo Equity· $80M
2018-05-23IPO
2018-02-01Series C· $200M
Leadership Team
Recent News
GlobeNewswire
2026-01-13
2025-12-09
2025-10-29
Company data provided by crunchbase